Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.04B |
| 2 |
Verizon
VZ
|
+$459M |
| 3 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
+$448M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$738M |
| 2 |
iShares MBS ETF
MBB
|
+$390M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$216M |
| 4 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$202M |
| 5 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$186M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.49% |
| 2 | Financials | 13.78% |
| 3 | Healthcare | 13.39% |
| 4 | Industrials | 9.54% |
| 5 | Consumer Discretionary | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Smith & Wesson
SWBI
$653M
| $6.75M | ﹤0.01% |
777,785
+89,502
| +13% | +$943K |
|
2052
Iovance Biotherapeutics
IOVA
$1.94B
| $6.74M | ﹤0.01% |
1,054,844
+27,384
| +3% | +$214K |
|
2053
Clean Energy Fuels
CLNE
$418M
| $6.73M | ﹤0.01% |
1,293,749
+38,101
| +3% | +$234K |
|
2054
Gogo Inc
GOGO
$603M
| $6.72M | ﹤0.01% |
455,387
+9,325
| +2% | +$135K |
|
|
CHCT
2055
Community Healthcare Trust
CHCT
$529M
| $6.71M | ﹤0.01% |
187,329
+14,460
| +8% | +$493K |
|
2056
SkinHealth Systems
SKIN
$92.2M
| $6.71M | ﹤0.01% |
736,909
-18,780
| -2% | -$203K |
|
2057
Rhythm Pharmaceuticals
RYTM
$6.86B
| $6.7M | ﹤0.01% |
229,916
+25,647
| +13% | +$659K |
|
2058
Hillman Solutions
HLMN
$1.6B
| $6.69M | ﹤0.01% |
928,527
+20,390
| +2% | +$153K |
|
|
RADI
2059
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
| $6.68M | ﹤0.01% |
565,446
+13,037
| +2% | +$135K |
|
|
SUMO
2060
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
| $6.68M | ﹤0.01% |
824,196
+41,941
| +5% | +$319K |
|
|
MNTV
2061
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $6.68M | ﹤0.01% |
953,601
+23,040
| +2% | +$166K |
|
|
TDAY
2062
USA Today Co
TDAY
$1.31B
| $6.67M | ﹤0.01% |
3,286,180
+384,556
| +13% | +$738K |
|
|
CNSL
2063
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $6.63M | ﹤0.01% |
1,850,697
+122,780
| +7% | +$545K |
|
|
PYCR
2064
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $6.62M | ﹤0.01% |
270,480
+4,188
| +2% | +$116K |
|
2065
SiriusPoint
SPNT
$2.76B
| $6.57M | ﹤0.01% |
1,113,276
+19,930
| +2% | +$117K |
|
2066
Banc of California
BANC
$3.05B
| $6.56M | ﹤0.01% |
411,952
+12,681
| +3% | +$207K |
|
|
NWLI
2067
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $6.56M | ﹤0.01% |
23,350
+205
| +0.9% | +$43.7K |
|
|
AGNT
2068
AGNT Inc
AGNT
$666M
| $6.55M | ﹤0.01% |
591,422
+3,522
| +0.6% | +$42.7K |
|
2069
Mercer International
MERC
$44.2M
| $6.55M | ﹤0.01% |
562,932
+92,636
| +20% | +$1.23M |
|
|
VTYX
2070
DELISTED
Ventyx Biosciences
VTYX
| $6.55M | ﹤0.01% |
199,773
+39,311
| +24% | +$1.16M |
|
2071
Regenxbio
RGNX
$629M
| $6.52M | ﹤0.01% |
287,567
+8,739
| +3% | +$198K |
|
2072
iShares Intermediate Government/Credit Bond ETF
GVI
$3.77B
| $6.49M | ﹤0.01% |
63,357
-7,364
| -10% | -$752K |
|
2073
Aclaris Therapeutics
ACRS
$753M
| $6.49M | ﹤0.01% |
412,133
+9,579
| +2% | +$154K |
|
2074
Center Bancorp
CNOB
$1.68B
| $6.47M | ﹤0.01% |
267,362
+5,411
| +2% | +$133K |
|
|
VTLE
2075
DELISTED
Vital Energy
VTLE
| $6.44M | ﹤0.01% |
125,147
+280
| +0.2% | +$17.3K |
|
Similar funds
Charles Schwab's Q4 2022 Portfolio in Review
As of Q4 2022, Charles Schwab held 3,632 positions worth $310B, up 11% from $279B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Charles Schwab's Q4 2022 filing shows 124 new, 2,654 increased, 459 reduced and 86 closed positions. Its largest new stake was iShares 0-5 Year TIPS Bond ETF: 4,612,793 shares worth $447M. The largest sale was Vanguard Intermediate-Term Treasury ETF, an estimated $738M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2022 buy was iShares 0-5 Year TIPS Bond ETF: 4,612,793 shares worth $447M.
- Charles Schwab added most to iShares 7-10 Year Treasury Bond ETF in Q4 2022, an estimated $1.04B increase.
- Charles Schwab's biggest Q4 2022 reduction was Vanguard Intermediate-Term Treasury ETF, cutting an estimated $738M.
- Charles Schwab fully exited Duke Realty Corp. in Q4 2022, selling an estimated $175M.
- Charles Schwab's ten largest holdings make up 16% of its $310B portfolio in Q4 2022.
- Charles Schwab opened 124 new positions and closed 86 in Q4 2022.
- Charles Schwab's portfolio value rose 11% quarter-over-quarter to $310B.
Based on Charles Schwab's 13F filing for Q4 2022, filed 13 Feb 2023.